We are live on
!
Find out more
TCP
Tyndall Capital Partners Portfolio holdings
AUM
$452K
1-Year Est. Return
26.52%
This Fund
S&P 500
This Quarter
Est. Return
-4.48%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$527K
AUM Growth
-$23.6K
(-4.3%)
Cap. Flow
+$1.11K
Cap. Flow
% of AUM
0.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cyclerion Therapeutics
CYCN
|
+$1.11K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CCM
HIP
BPWM
NP
CP
AI
CAWM
ADIM
Tyndall Capital Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Tyndall Capital Partners held 1 position worth $527K, down 4.3% from $551K the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 0%. Tyndall Capital Partners opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Tyndall Capital Partners added most to Cyclerion Therapeutics in Q1 2024, an estimated $1.11K increase.
- Tyndall Capital Partners's ten largest holdings make up 100% of its $527K portfolio in Q1 2024.
- Tyndall Capital Partners opened 0 new positions and closed 0 in Q1 2024.
- Tyndall Capital Partners's portfolio value fell 4.3% quarter-over-quarter to $527K.
Based on Tyndall Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.